Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Cardiff Oncology (CRDF) Other Gross PP&E Adjustments (2016 - 2025)

Cardiff Oncology's Other Gross PP&E Adjustments history spans 15 years, with the latest figure at $2.8 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 6.01% year-over-year to $2.8 million; the TTM value through Dec 2025 reached $2.8 million, up 6.01%, while the annual FY2025 figure was $2.8 million, 6.01% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $2.8 million at Cardiff Oncology, up from -$764000.0 in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $4.2 million in Q2 2025 and bottomed at -$764000.0 in Q3 2025.
  • The 5-year median for Other Gross PP&E Adjustments is $2.7 million (2023), against an average of $2.4 million.
  • The largest annual shift saw Other Gross PP&E Adjustments skyrocketed 1613.85% in 2022 before it tumbled 120.4% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $65000.0 in 2021, then surged by 1613.85% to $1.1 million in 2022, then surged by 68.31% to $1.9 million in 2023, then soared by 39.41% to $2.6 million in 2024, then grew by 6.01% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for CRDF's Other Gross PP&E Adjustments are $2.8 million (Q4 2025), -$764000.0 (Q3 2025), and $4.2 million (Q2 2025).